Mark Selby, chairman and CEO of CanadaNickel , talks to Mining Journal about the junior miner's Crawford nickel-cobalt sulphide discovery and what investors can expect to see in the coming months. Watch the interview here: canadanickel miningfinance
We occasionally send commercial message on behalf our partners. Submitting your details tells and ticking the box us that you’re OK with this and you also agree to our privacy and cookie policy. You can opt out of these communications at any time by contacting events@aspermontmedia.
comWe’d like to send you information on Aspermont events and other Aspermont services that are relevant to you. Submitting your details and ticking the box tells us that you’re OK with this and you also agree to our privacy and cookie policy at the bottom of the Future of Mining website. You can opt out of these communications at any time by contacting [email protected].
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Immigration fuels Canada's largest population growth of over 1 millionThe unprecedented surge in numbers is largely due to immigration, the government says.
Lire la suite »
US politicians attack TikTok's CEO and demand a full ban of the app across the USCountries including the United States, UK, Canada have banned the app from government devices
Lire la suite »
I thought Race Across the World's Canada trip would be too easy. I was wrongDon't they speak English in Canada? Isn't it basically Britain, but bigger? Then came out the bear spray...
Lire la suite »
Post-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort - BMC Pulmonary MedicineBackground The pathophysiology, evolution, and associated outcomes of post-COVID dyspnea remain unknown. The aim of this study was to determine the prevalence, severity, and predictors of dyspnea 12 months following hospitalization for COVID-19, and to describe the respiratory, cardiac, and patient-reported outcomes in patients with post-COVID dyspnea. Methods We enrolled a prospective cohort of all adult patients admitted to 2 academic hospitals in Vancouver, Canada with PCR-confirmed SARS-CoV-2 during the first wave of COVID between March and June 2020. Dyspnea was measured 3, 6, and 12 months after initial symptom onset using the University of California San Diego Shortness of Breath Questionnaire. Results A total of 76 patients were included. Clinically meaningful dyspnea (baseline score | 10 points) was present in 49% of patients at 3 months and 46% at 12 months following COVID-19. Between 3 and 12 months post-COVID-19, 24% patients had a clinically meaningful worsening in their dyspnea, 49% had no meaningful change, and 28% had a clinically meaningful improvement in their dyspnea. There was worse sleep, mood, quality of life, and frailty in patients with clinically meaningful dyspnea at 12 months post-COVID infection compared to patients without dyspnea. There was no difference in PFT findings, troponin, or BNP comparing patients with and without clinically meaningful dyspnea at 12 months. Severity of dyspnea and depressive symptoms at 3 months predicted severity of dyspnea at 12 months. Conclusions Post-COVID dyspnea is common, persistent, and negatively impacts quality of life. Mood abnormalities may play a causative role in post-COVID dyspnea in addition to potential cardiorespiratory abnormalities. Dyspnea and depression at initial follow-up predict longer-term post-COVID dyspnea, emphasizing that standardized dyspnea and mood assessment following COVID-19 may identify patients at high risk of post-COVID dyspnea and facilitating early and effective managem
Lire la suite »
US Fed raises interest rates despite banking crisis as focus switches to Bank of EnglandBritish banks 'strong and robust', MPs told, but volatility could expose weakness in financial system and raise costs for UK borrowers
Lire la suite »